Schedule 13D ownership disclosure
PYXIS ONCOLOGY INC
Common Stock, par value $0.001 per share · CUSIP: 747324101
Event date: 2025-03-31
- Filing-level shares
- 7,543,007
- Percent of class
- 11.21%
- Lara Sullivan, M.D.Reported CIK 0001769457
Shares: 7,543,007 · Class: 11.21%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-049860
- Form type
- SCHEDULE 13D/A
- Filer
- Pyxis Oncology, Inc.
- CIK
- CIK 1782223
- Filed
- Apr 02, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13D beneficial ownership